|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00348 CHINAHEALTHWISE
Nominal 
0.082 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -61.536% | -18.039% | -27.539% | -4.885% | -19.186% |
| ROAE (%) | -188.131% | -32.723% | -42.115% | -8.097% | -31.797% |
| Return on Capital Employed (%) | -2003.245% | -25.492% | -52.993% | -6.569% | -37.135% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 41.208% | 37.499% | 53.501% | 44.291% | 28.251% |
| EBITDA Margin (%) | -80.272% | -32.240% | -52.900% | -32.892% | -31.117% |
| Pre-tax Profit Margin (%) | -90.255% | -39.703% | -59.137% | -52.903% | -40.755% |
| Net Profit Margin (%) | -91.963% | -38.206% | -60.587% | -18.296% | -40.115% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.977 X | 3.679 X | 1.687 X | 5.732 X | 2.066 X |
| Quick Ratio (X) | 0.585 X | 2.942 X | 1.180 X | 4.779 X | 1.805 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 97.062% | 51.801% | 38.533% | 31.774% | 45.411% |
| Total Debt / Total Assets (%) | 72.760% | 38.206% | 28.927% | 26.208% | 24.567% |
| Net Debt / Total Assets (%) | 63.125% | 32.348% | 16.190% | 18.188% | 16.701% |
| Total Debt / Shareholders' Funds (%) | 2476.126% | 79.266% | 47.062% | 38.413% | 45.003% |
| Long Term Debt / Shareholders' Funds (%) | 48.863% | 53.290% | 0.719% | 29.579% | 1.915% |
| Net Debt / Shareholders' Funds (%) | 2148.226% | 67.113% | 26.339% | 26.658% | 30.594% |
| Net Cash / (Debt) ($) | (94.479M) | (93.052M) | (50.852M) | (78.986M) | (99.941M) |
| Net Cash / (Debt) per share ($) | (0.123) | (0.121) | (0.066) | (0.103) | (0.127) |
| Total Debt / Capital Employed (%) | 1621.259% | 51.621% | 46.726% | 29.645% | 43.904% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 235.795 Day | 238.092 Day | 250.788 Day | 277.808 Day | 115.440 Day |
| Receivables Turnover (Day) | 14.126 Day | 14.755 Day | 13.338 Day | 61.220 Day | 47.358 Day |
| Payables Turnover (Day) | 58.670 Day | 53.153 Day | 30.371 Day | 143.507 Day | 80.664 Day |
| Remarks: | Real time quote last updated: 11/11/2024 09:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -28,663,000 |
| %Change | -10.040% |
| EPS / (LPS) | HKD -0.037 |
| NBV Per Share ($) | HKD -0.031 |